Seeing Is Believing
TARS is currently covered by 5 analysts with an average price target of $97. This is a potential upside of $18.39 (23.39%) from yesterday's end of day stock price of $78.61.
Tarsus Pharmaceuticals's activity chart (see below) currently has 78 price targets and 64 ratings on display. The stock rating distribution of TARS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 83.65% with an average time for these price targets to be met of 429.65 days.
Highest price target for TARS is $116, Lowest price target is $88, average price target is $97.
Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 24-Sep-2026. First documented stock forecast 10-Nov-2020.
Currently out of the existing stock ratings of TARS, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Sep-2026
$116
$40.31 (53.26%)
$51
6 days ago
(24-Sep-2026)
3/4 (75%)
$40.04 (52.71%)
111
Buy Since 25-Feb-2026
$100
$24.31 (32.12%)
$105
1 months 18 days ago
(12-Aug-2026)
2/4 (50%)
$29.98 (42.82%)
646
Buy Since 31-Jul-2026
$98
$22.31 (29.48%)
$100
1 months 30 days ago
(31-Jul-2026)
0/2 (0%)
$38.96 (65.99%)
Buy Since 27-May-2025
$88
$12.31 (16.26%)
$88
2 months 21 days ago
(09-Jul-2026)
4/4 (100%)
$23.86 (37.20%)
160
Buy Since 16-Jun-2023
$90
$14.31 (18.91%)
$87
7 months 5 days ago
(25-Feb-2026)
7/7 (100%)
$17.35 (23.88%)
375
What is TARS (Tarsus Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on TARS (Tarsus Pharmaceuticals)?
Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals)?
Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals)?
Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals)?